RecruitingPhase 3NCT05512403

Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics

Studying Glial tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Central Hospital, Nancy, France
Principal Investigator
Antoine VERGER, MD, PhD
CHRU Nancy
Intervention
PET/CT with 18F-DOPA(drug)
Enrollment
88 enrolled
Eligibility
18-75 years · All sexes
Timeline
20232026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05512403 on ClinicalTrials.gov

Other trials for Glial tumor

Additional recruiting or active studies for the same condition.

See all trials for Glial tumor

← Back to all trials